@misc{indiciaec1b7e7e2d1d0,
  title = {Beyond the limitation of randomized controlled trials (RCTs)-current drug repositioning by using human induced pluripotent stem (iPS) cells technology-},
  author = {Okabe, M. and Reproductive Medicine Institute Japan,},
  year = {2017},
  doi = {10.1101/111435},
  url = {https://www.biorxiv.org/content/10.1101/111435v1},
  note = {Source identifier: 10.1101/111435}
}